Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Braz. j. microbiol ; 46(3): 861-865, July-Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-755806

ABSTRACT

Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18th(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.

.


Subject(s)
Animals , Chick Embryo , Chickens/virology , Newcastle disease virus/pathogenicity , Poultry Diseases/prevention & control , Vaccines, Attenuated/therapeutic use , Viral Vaccines/therapeutic use , Cell Culture Techniques , Cells, Cultured , Chickens/immunology , Newcastle disease virus/classification , Newcastle disease virus/growth & development , Primary Cell Culture , Poultry Diseases/immunology , Poultry Diseases/virology , Vaccination , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/immunology , Viral Vaccines/adverse effects , Viral Vaccines/immunology
2.
Pakistan Journal of Pharmaceutical Sciences. 2009; 22 (4): 410-414
in English | IMEMR | ID: emr-102264

ABSTRACT

GMP conditions commands to control adequately the quality of APIs by checking the levels of residual solvents. Organic solvents such as acetone, ethyl acetate, isopropyl alcohol, methanol, tetrahydrofuran and toluene frequently used in pharmaceutical industry for the manufacturing of Active Pharmaceutical ingredients [APIs]. A selective Gas Chromatographic [GC] method has been developed and validated as per ICH guidelines for residual solvent analysis in 10 different hydro chloride salts of APIs. Residual solvents in APIs were monitored using gas chromatography [GC] with Flame Ionisation detector [FID]. The separation was carried out on BP 624 column [30m X 0.53mm i.d. X 0.25micro m coating thickness], using GC 17 A shimadzu, with nitrogen as carrier gas in the split mode by direct injection method. The method described is simple, sensitive, rugged, reliable and reproducible for the quantitation of acetone, ethyl acetate, isopropyl alcohol, methanol, tetrahydrofuran and toluene at residual level from hydrochloride chloride salts of APIs


Subject(s)
Solvents/analysis , Drug Contamination , Reproducibility of Results , Dimethyl Sulfoxide , Chromatography, Gas , Flame Ionization
SELECTION OF CITATIONS
SEARCH DETAIL